サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1758788

GABAサプリメントの世界市場

GABA Supplements

出版日
ページ情報
英文 279 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.89円
GABAサプリメントの世界市場
出版日: 2025年06月30日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 279 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

GABAサプリメントの世界市場は2030年までに6,080万米ドルに達する見込み

2024年に4,550万米ドルと推定されるGABAサプリメントの世界市場は、2024年から2030年にかけてCAGR 4.9%で成長し、2030年には6,080万米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるカプセル剤は、CAGR 5.4%を記録し、分析期間終了時には2,950万米ドルに達すると予測されます。ロゼンジ剤形セグメントの成長率は、分析期間中CAGR 5.5％と推定されます。

米国市場は1,240万米ドルと推定、中国はCAGR 9.0％で成長予測

米国のGABAサプリメント市場は2024年に1,240万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024年から2030年にかけてCAGR 9.0％で推移し、2030年には1,280万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.0％と3.9％と予測されています。欧州では、ドイツがCAGR 2.9%で成長すると予測されています。

世界の「GABAサプリメント」市場- 主要動向と促進要因のまとめ

健康志向の消費者の間で高まる「GABAサプリメント」人気の要因は？

γ-アミノ酪酸（GABA）サプリメントは、メンタルヘルス、ストレス管理、ホリスティックな幸福感に対する消費者の意識が高まり続けている近年、絶大な支持を得ています。もともと臨床神経科学界で理解されていたGABAの役割は、天然に存在する神経伝達物質として、現在ではウェルネスの主流用語となっています。中枢神経系の抑制剤として、GABAはリラクゼーションを促し、神経細胞の興奮性を低下させ、睡眠の質の向上、不安の軽減、感情のバランスに一般的に関連しています。ストレスや不眠症に対する非医薬品的介入に対する需要が急増していることから、特に北米と欧州でGABAサプリメントが脚光を浴びています。ミレニアル世代とZ世代は、高ストレス環境とソーシャル・メディアの影響により、感情的回復力をサポートするためにアダプトゲンやGABAなどの気分増強剤に注目しています。一方、eコマース・プラットフォームとウェルネス・インフルエンサーは、製品の知名度をさらに高め、透明性のある表示と臨床的検証を通じて消費者の信頼を育んでいます。メンタル・ヘルスがデスティグマ化するにつれ、安全な市販のメンタル・ウェルネス製品に対する需要は着実に増え続けています。

なぜ製剤やデリバリー形態の革新が台頭しているのか？

GABAサプリメント市場は、製剤やデリバリー方法の革新によって形を変え、メーカーと消費者双方に新たな価値提案を生み出しています。従来のカプセルや錠剤から、グミ、発泡性粉末、舌下スプレーに至るまで、ユーザーフレンドリーなフォーマットへのシフトは、服薬アドヒアランスを高め、幅広い層にアピールしています。各ブランドはまた、GABAにL-テアニン、マグネシウム、メラトニン、5-HTPなどの補完成分を配合することで、ホリスティックなストレスと睡眠の解決策を目指した相乗効果のあるブレンドを生み出しています。ビーガン、グルテンフリー、非遺伝子組み換えの製剤の人気は、クリーンラベル製品を求める幅広い消費者動向を反映しています。マイクロカプセル化やナノ送達システムといった技術の進歩は、生物学的利用能と安定性を高めるために活用されており、GABAの血液脳関門透過性に関する長年の懸念に対処しています。さらに、プライベートブランドの拡大や有名人が支援するブランドは、美的感覚に優れ、ライフスタイルに重点を置いた製品を導入することで、従来のサプリメント・ヒエラルキーを破壊しています。こうしたイノベーションは、もはや薬局や健康ショップに限定されるものではなく、オンライン・ウェルネス・ブティックや定期購入モデルを通じて主流となっています。

市場の進化を促す人口動態と流通チャネルは？

GABAサプリメントの消費は、もはやニッチな健康志向のグループに限定されるものではなく、幅広い年齢層とライフスタイルに広がっています。学業や職場でのストレスの高まりから、若い専門職や学生が主なユーザーである一方、睡眠をサポートする効果や認知の健康における潜在的な役割から、高齢者のGABAへの関心も高まっています。女性中心のウェルネス・ブランドは、PMSに関連した気分の落ち込みや更年期のストレスに対応する的を絞った製剤を製造しており、女性層で強い支持を集めています。地域的には、北米が市場シェアでリードしているが、アジア太平洋では、特に日本、南米、インドの都市部で採用が急増しています。薬局、健康食品店、栄養専門店は依然として重要な流通チャネルであるが、ウェルネスに特化したコンテンツ・マーケティングとインフルエンサーの支持を原動力とするeコマースの爆発的成長が、新たなベンチマークを打ち立てています。デジタル・プラットフォームは、製品の視認性向上、消費者との直接的なエンゲージメント、AIを活用したレコメンデーションによるカスタマイズを提供し、消費者がGABAサプリメントを探求し購入する方法を再構築しています。

GABAサプリメント市場の成長にはいくつかの要因があります。

GABAサプリメント市場の成長は、消費者の健康に対する優先順位の進化、製品イノベーション、デジタル小売の変革など、いくつかの要因によってもたらされます。主な要因の1つは、不安、不眠、ストレス関連疾患の世界の増加で、安全で自然な気分安定剤への需要が高まっています。第二に、栄養補助食品が合法的な健康介入として受け入れられつつあること（特に規制の枠組みがしっかりしている地域で）が、消費者の信頼と小売業者の在庫の両方を押し上げています。第三に、フィットネス、マインドフルネス、サプリメントを組み合わせたハイブリッド・ウェルネス・ルーティンの台頭が、GABA製品にとって肥沃な土壌を形成しています。さらに、風味の革新、年齢別処方、パーソナライゼーション・アルゴリズムによる製品の多様化が、新たな消費者層を引き付けています。市場の成長は、ヘルスケア支出の増加や可処分所得の増加、特に予防的ウェルネスが重要視される新興国でも支えられています。さらに、GABAサプリメントの有効性を裏付ける臨床研究が、開業医と消費者の双方にこれらの製品を日常的な養生法に組み込むことを促し、長期的な需要を持続させています。

セグメント

形態（カプセル剤、ロゼンジ剤、粉末剤、グミ剤）;流通チャネル（オンライン流通チャネル、薬局流通チャネル、スーパーマーケット／ハイパーマーケット、その他の流通チャネル）

調査対象企業の例（注目の36社）

  • Amazing Nutrition
  • Aurobindo Pharma
  • Bloomage Biotech
  • Bluebonnet Nutrition
  • Country Life
  • Doctor's Best
  • Douglas Laboratories
  • Enzymatic Therapy
  • Garden of Life
  • Guangdong Luckerkong Biotech
  • Horbaach
  • Integrative Therapeutics
  • Jarrow Formulas
  • Klaire Labs
  • Kyowa Hakko
  • Life Extension
  • Natrol
  • Nature's Truth
  • NOW Foods
  • NutraBio

AI統合

私たちは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP36968

Global GABA Supplements Market to Reach US$60.8 Million by 2030

The global market for GABA Supplements estimated at US$45.5 Million in the year 2024, is expected to reach US$60.8 Million by 2030, growing at a CAGR of 4.9% over the analysis period 2024-2030. Capsules Form, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$29.5 Million by the end of the analysis period. Growth in the Lozenges Form segment is estimated at 5.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$12.4 Million While China is Forecast to Grow at 9.0% CAGR

The GABA Supplements market in the U.S. is estimated at US$12.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$12.8 Million by the year 2030 trailing a CAGR of 9.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.0% and 3.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Global "GABA Supplements" Market - Key Trends & Drivers Summarized

What Fuels the Rising Popularity of GABA Supplements Among Health-Conscious Consumers?

Gamma-Aminobutyric Acid (GABA) supplements have gained immense traction in recent years as consumer awareness around mental health, stress management, and holistic well-being continues to surge. Originally understood in clinical neuroscience circles, GABA's role as a naturally occurring neurotransmitter has now entered mainstream wellness vocabulary. As a central nervous system depressant, GABA promotes relaxation, reduces neuronal excitability, and is commonly associated with improved sleep quality, reduced anxiety, and emotional balance. A burgeoning demand for non-pharmaceutical interventions for stress and insomnia has catapulted GABA supplements into the limelight, particularly in North America and Europe. Millennials and Gen Z, driven by high-stress environments and social media influence, are turning to adaptogens and mood enhancers such as GABA to support emotional resilience. Meanwhile, e-commerce platforms and wellness influencers have further amplified product visibility, fostering consumer trust through transparent labeling and clinical validation. As mental health becomes destigmatized, the demand for safe, over-the-counter mental wellness products continues its steady rise.

Why Are Innovations in Formulations and Delivery Formats Gaining Ground?

The GABA supplements market is being reshaped by innovation in formulations and delivery methods, creating new value propositions for manufacturers and consumers alike. From conventional capsules and tablets to gummies, effervescent powders, and sublingual sprays, the shift toward user-friendly formats is enhancing adherence and widening demographic appeal. Brands are also infusing GABA with complementary ingredients such as L-theanine, magnesium, melatonin, and 5-HTP, thereby creating synergistic blends aimed at holistic stress and sleep solutions. The popularity of vegan, gluten-free, and non-GMO formulations reflects a broader consumer trend toward clean-label products. Technological advancements such as microencapsulation and nano-delivery systems are being leveraged to increase bioavailability and stability, addressing the long-standing concern about GABA’s blood-brain barrier permeability. Additionally, private-label expansion and celebrity-backed brands are disrupting traditional supplement hierarchies by introducing high-aesthetic, lifestyle-focused offerings. These innovations are no longer limited to pharmacies and health stores but are now mainstreamed via online wellness boutiques and subscription models.

Which Demographics and Distribution Channels Are Driving Market Evolution?

GABA supplement consumption is no longer confined to niche health-focused groups but is witnessing uptake across a broad spectrum of age groups and lifestyles. While young professionals and students are primary users due to heightened academic and workplace stress, seniors are also showing increased interest in GABA for its sleep-support benefits and potential role in cognitive health. Women-centric wellness brands are crafting targeted formulations addressing PMS-related mood swings and menopausal stress, creating strong traction in female demographic segments. Geographically, while North America leads in terms of market share, Asia-Pacific is witnessing a sharp uptick in adoption, particularly in urban centers of Japan, South Korea, and India. Pharmacies, health and wellness stores, and specialty nutrition outlets remain important distribution channels; however, the explosive growth of e-commerce-powered by wellness-focused content marketing and influencer endorsements-is setting new benchmarks. Digital platforms offer greater product visibility, direct consumer engagement, and customization through AI-powered recommendations, reshaping how consumers explore and purchase GABA supplements.

The Growth in the GABA Supplements Market Is Driven by Several Factors…

The growth in the GABA supplements market is driven by several factors including evolving consumer health priorities, product innovation, and digital retail transformation. One key driver is the global uptick in anxiety, insomnia, and stress-related disorders, which has heightened demand for safe, natural mood stabilizers. Second, the increasing acceptance of nutraceuticals as a legitimate health intervention-particularly in regions with robust regulatory frameworks-is boosting both consumer confidence and retailer inventory. Third, the rise of hybrid wellness routines that combine fitness, mindfulness, and supplementation is creating a fertile ground for GABA products. Further, product diversification through flavor innovation, age-specific formulations, and personalization algorithms is attracting new consumer segments. Market growth is also supported by increasing healthcare expenditure and rising disposable incomes, especially in emerging economies where preventive wellness is gaining importance. Additionally, clinical research supporting the efficacy of GABA supplements is encouraging both practitioners and consumers to integrate these products into daily regimens, sustaining long-term demand.

SCOPE OF STUDY:

The report analyzes the GABA Supplements market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Form (Capsules Form, Lozenges Form, Powder Form, Gummies Form); Distribution Channel (Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets, Other Distribution Channels)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Amazing Nutrition
  • Aurobindo Pharma
  • Bloomage Biotech
  • Bluebonnet Nutrition
  • Country Life
  • Doctor's Best
  • Douglas Laboratories
  • Enzymatic Therapy
  • Garden of Life
  • Guangdong Luckerkong Biotech
  • Horbaach
  • Integrative Therapeutics
  • Jarrow Formulas
  • Klaire Labs
  • Kyowa Hakko
  • Life Extension
  • Natrol
  • Nature's Truth
  • NOW Foods
  • NutraBio

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • GABA Supplements - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Prevalence of Stress and Anxiety Disorders Spurs Demand for GABA-Based Supplements
    • Consumer Shift Toward Natural Mood Enhancers Strengthens Market for Non-Prescription Solutions
    • Rising Interest in Cognitive Wellness Expands the Addressable Market for Neuroactive Compounds
    • Product Innovation in Gummies and Functional Beverages Drives Adoption of GABA Ingredients
    • E-commerce Growth and DTC Health Brands Accelerate Access to GABA Formulations
    • Clean Label and Plant-Derived Trends Throw Spotlight on Naturally Sourced GABA Supplements
    • Regulatory Flexibility in Nutraceutical Labeling Encourages New Product Launches
    • Increased Scientific Validation of GABAs Effects Strengthens Consumer Confidence and Repeat Usage
    • Rising Popularity of Sleep Aids and Relaxation Products Propels Nighttime GABA Supplement Demand
    • Celebrity and Influencer Endorsements Amplify Market Visibility and Product Differentiation
    • Integrative Health Practices Expand Use of GABA in Holistic Wellness Programs
    • Stacking with Nootropic Formulations Generates Demand for Multi-Ingredient GABA Products
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World GABA Supplements Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for GABA Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for GABA Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for GABA Supplements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Capsules Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Capsules Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Capsules Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Lozenges Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Lozenges Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Lozenges Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Powder Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Powder Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Powder Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Gummies Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Gummies Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Gummies Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Online Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Supermarkets / Hypermarkets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Supermarkets / Hypermarkets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Supermarkets / Hypermarkets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 34: USA 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • JAPAN
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • CHINA
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 49: China 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 52: China 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • EUROPE
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for GABA Supplements by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for GABA Supplements by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for GABA Supplements by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • FRANCE
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 64: France 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 67: France 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • GERMANY
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 82: UK 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 85: UK 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for GABA Supplements by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for GABA Supplements by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for GABA Supplements by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • INDIA
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 121: India 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 124: India 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for GABA Supplements by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for GABA Supplements by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for GABA Supplements by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for GABA Supplements by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for GABA Supplements by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for GABA Supplements by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030
  • AFRICA
    • GABA Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for GABA Supplements by Form - Capsules Form, Lozenges Form, Powder Form and Gummies Form Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for GABA Supplements by Form - Percentage Breakdown of Value Sales for Capsules Form, Lozenges Form, Powder Form and Gummies Form for the Years 2014, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for GABA Supplements by Distribution Channel - Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for GABA Supplements by Distribution Channel - Percentage Breakdown of Value Sales for Online Distribution Channel, Pharmacies Distribution Channel, Supermarkets / Hypermarkets and Other Distribution Channels for the Years 2014, 2025 & 2030

IV. COMPETITION